Cutaneous mastocytosis associated with a mixed germ cell tumour of the ovary: Report of a case and review of the literature

British Journal of Dermatology

Volumn 145, Issue 2, 2001, Pages 309-312

  Miyagawa, S ^a   Hirota, S ^a,b   Park, Y D ^a   Yamasaki, M ^a   Daikoku, N ^a   Morikawa, H ^a   Yoshioka, A ^a   Kitamura, Y ^a,b   Ichijima, K ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

C kit; Germ cell tumour; Mastocytosis; Ovary; Point mutations

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; PIRARUBICIN; STEM CELL FACTOR RECEPTOR;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CHILD; CLINICAL FEATURE; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MASTOCYTOSIS; MIXED TUMOR; OVARY CARCINOMA; POINT MUTATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; FEMALE; GERMINOMA; HUMANS; MASTOCYTOSIS; OVARIAN NEOPLASMS; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0034794136     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04322.x     Document Type: Article

References (30)

1. Recent advances in mastocytosis research: Summary of the Vienna mastocytosis meeting 1998
2. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis
3. Expression of stem cell factor in cutaneous mastocytosis
4. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
5. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in the peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
6. c-kit mutation in a population of patients with mastocytosis
7. Identification of activating c-kit mutations in adult, but not in childhood-onset indolent mastocytosis: A possible explanation for divergent clinical behavior
8. Systemic mast cell disease associated with primary mediastinal germ cell tumor
9. Systemic mastocytosis following mediastinal germ cell tumor: An association confirmed
10. Malignant germ cell tumor and urticaria pigmentosa
11. Systemic mastocytosis following a malignant ovarian germ cell tumour
12. Systemic mast cell disease associated with primary ovarian mixed malignant germ cell tumor
13. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
14. Hematologic malignancies associated with primary mediastinal germ-cell tumors
15. Association between mediastinal germ cell tumors and hematologic malignancies: Report of two cases and review of the literature
16. Case reports of the Massachusetts General Hospital
17. Hematologic neoplasia associated with primary mediastinal germ-cell tumors
18. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors
19. The clonal nature of mediastinal germ cell tumors and acute myelogenous leukemia: A case report and review of the literature
20. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors
21. Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes
22. Significance of systemic mast cell disease with associated hematologic disorders
23. Hematologic malignancies occurring in patients with urticaria pigmentosa
24. Acute leukaemia following high-dose chemoradiotherapy with bone marrow rescue for ovarian teratoma
25. Secondary leukemia associated with a conventional dose of etoposide: Review of serial germ cell tumor protocols
26. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles
27. Stepwise requirement of c-kit tyrosine kinase in mouse ovarian follicle development
28. + bone marrow progenitor cells
29. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells
30. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis